Emerging research suggests that nanotechnology-enhanced delivery of lutein could revolutionise early treatment strategies for diabetic retinopathy, targeting neurovascular damage before irreversible vision loss occurs. Diabetic retinopathy is still one of the main causes of sight loss in working-age adults, but…
Lilly has secured FDA approval for its innovative weekly insulin, Onswik, offering a new alternative for adults with type 2 diabetes seeking to minimise daily injections and streamline their treatment regime. The U.S. Food and Drug Administration has approved Eli…
New large-scale studies presented at EASD 2026 suggest that continuous glucose monitoring may significantly improve long-term health outcomes for adults with type 2 diabetes, including lower mortality and fewer cardiovascular complications. Continuous glucose monitoring could be linked to better long-term…
Recent research presented at the European Association for the Study of Diabetes reveals how red meat consumption, ultra-processed foods, and physical activity levels can significantly impact the risk of developing type 2 diabetes, even among those with genetic predispositions. Two…
Diabetes Meal Plans launches a new weekly menu featuring meat-free, lower-carbohydrate dishes with personalised options, combining practical support tools to help individuals with type 2 diabetes and prediabetes manage their condition more effectively. Diabetes Meal Plans has published its latest…
Diabetes Meal Plans unveils its newest weekly menu focusing on plant-based dishes and seasonal adjustments, aiming to enhance blood sugar control and support healthy habits for people with type 2 diabetes and prediabetes. Diabetes Meal Plans has released its latest…
A personal recount of Robert Gawley’s experiences highlights the dramatic advances in diabetes management from manual injections and basic tools to sophisticated, tailored therapies, reflecting a century of medical innovation. Robert Gawley’s memory of his diagnosis still begins with a…
Recent comparisons reveal that while both watermelon and papaya can be enjoyed in moderation, papaya’s higher fibre content and moderate glycaemic index may offer a slight edge for those managing blood sugar levels, challenging common assumptions about sweetness and glycaemic…
Regenxbio reports promising three-year follow-up data for its innovative single-dose gene therapy targeting diabetic retinopathy, highlighting sustained efficacy and safety, as it advances to larger clinical trials. REGENXBIO has reported new three-year follow-up data suggesting that its single-dose gene therapy…
Hong Kong doctor warns that cutting carbohydrates and increasing saturated fats may worsen metabolic health, emphasising individualised approaches based on personal fat thresholds and fat distribution rather than weight alone. Many people trying to improve their blood sugar are cutting…
